Annovis Bio Inc

ANVS

Company Profile

  • Business description

    Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

  • Contact

    101 Lindenwood Drive
    Suite 225
    MalvernPA19355
    USA

    T: +1 484 875-3192

    https://www.annovisbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    6

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,510.7043.700.52%
CAC 407,853.853.750.05%
DAX 4023,579.4212.880.05%
Dow JONES (US)42,410.101,160.722.81%
FTSE 1008,604.590.39-0.00%
HKSE23,108.27441.19-1.87%
NASDAQ18,708.34779.434.35%
Nikkei 22538,183.26539.001.43%
NZX 50 Index12,786.74109.990.87%
S&P 5005,844.19184.283.26%
S&P/ASX 2008,269.0035.500.43%
SSE Composite Index3,374.875.630.17%

Market Movers